A Pharmacokinetic Study of Single-Dose Intravenous Ustekinumab Delivered in 2 Different Liquid in Vial Formulations
Status:
Completed
Trial end date:
2014-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the pharmacokinetic (PK) (blood levels)
comparability of 2 different formulations of ustekinumab, 90 milligram per milliliter (mg/mL)
liquid in vial (LIV) and 5 mg/mL LIV, following a single intravenous administration of 6
milligram per kilogram (mg/kg) ustekinumab, diluted in saline, in healthy participants.